AzTrials
AzTrials

RehabilitationNCT04914624

Effects of Different Physical Therapy Programs on Pulmonary Rehabilitation in Patients With Lung Cancer

A study testing ACBT training, acpella®PEP and EDP-type II external diaphragm pacemaker in people with Rehabilitation, run by Sun Yat-sen University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study applies external diaphragm pacemaker and positive expiratory pressure therapy to patients who received thoracic surgeries, in order to explore the effects of different physical therapy programs on pulmonary rehabilitation in patients with lung cancer. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Rehabilitation
What is being tested?
ACBT training, acpella®PEP and EDP-type II external diaphragm pacemaker
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
90 participants
Where
1 siteChina
Study dates
1 May 2020to 30 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who are diagnosed with non-small cell lung cancer with clear pathological cytology by fiberoptic bronchoscopy and CT, and plan to undergo lobectomy or segmentectomy under general anesthesia for tracheal intubation;
  • Age 18-80 years old;
  • Those who have stable vital signs and can participate in this research;
  • Pulmonary function test FEV1/FVC>0.8.
  • Volunteer to participate in this research and sign an informed consent form.

Who cannot join

  • Pneumonectomy patients;
  • Wedge resection patients
  • Patients with distant metastasis of cancer;
  • Patients with other malignant tumors;
  • Severe complications occurred during the operation, and respiratory function training and testing are not allowed before and after Evaluator;
  • Patients with severe physical or mental illness who cannot cooperate with the test;
  • Patients with pacemakers, active tuberculosis, and pneumothorax.

Trial locations and contacts

1 site in 1 country.

Jiudi Zhong, Bachelor contact

+86 87343317

zhongjd@sysucc.org.cn

China1 site, 1 recruiting
  • Sun Yat sen University cancer center

    Guangzhou, Guangdong

    Jiudi Zhong, Bachelor, +86 13610181300, zhongjd@sysucc.org.cn

    Qinglin Wang, Bachelor, +86 13826293429, wangql@sysucc.org.cn

    Recruiting

Other trials in China

About this study

This study applies external diaphragm pacemaker and positive expiratory pressure therapy to patients who received thoracic surgeries, in order to explore the effects of different physical therapy programs on pulmonary rehabilitation in patients with lung cancer. As well as we hope that these physical training programs can effectively improve the lung function of patients, reduce postoperative pulmonary complications, hospitalization days, hospitalization expenses, etc.

Read the detailed description

This study applies external diaphragm pacemaker and positive expiratory pressure therapy to patients who received thoracic surgeries, ninety patients may be enrolled in this study.

Some metrics are used to evaluate the pulmonary rehabilitation status in postoperative patients which include pulmonary function test, 6-Min Walking Test,Borg index, complications incidence, chest tube draining time, and diaphragm muscle mobility.

Conditions
Rehabilitation
Being tested
ACBT training, acpella®PEP, EDP-type II external diaphragm pacemaker
Keywords
pulmonary rehabilitation, external diaphragm pacemaker, expiratory pressure therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ACBT trainingBehavioural

    Performed 5 days before surgery and one month after surgery, twice a day.

  • acpella®PEPDevice

    Continuously instruct patients to perform positive expiratory pressure training 5 days before surgery and one month after surgery, twice a day.

  • EDP-type II external diaphragm pacemakerDevice

    Use external diaphragm pacemaker to stimulate patients' diaphragms.

Study groups in NCT04914624
Study groupRoleWhat they receive
Regular ACBT trainingPlacebo comparatorIncluding quitting smoking, ACBT training, cough practicing.
Receives: Behavioral: ACBT training
Positive expiratory pressure therapyExperimentalUse acpella®PEP therapeutic system and regular nursing care.
Receives: Device: acpella®PEP
External diaphragm pacemakerExperimentalPatients are trained to use external diaphragm pacemaker and receive regular nursing care.
Receives: Device: EDP-type II external diaphragm pacemaker

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The change from baseline Forced Expiratory Volume In One Second at one month after surgery

    Evaluate the change of Forced Expiratory Volume In One Second before the surgery and one month after surgery by conducting Pulmonary Function Test on resectable NSCLC patients

    Measured: baseline (before the surgery), and one month after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jun 2021
  2. Study start1 May 2020
  3. Primary completion30 Nov 2021 (estimated)
  4. Study completion30 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04914624
Sponsor's protocol ID
2020-ZJD-001
Status last verified
May 2021
First submitted
30 Dec 2020
Last updated
4 Jun 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Chen X, Li C, Zeng L, Rong T, Lin P, Wang Q, Guo Z, Long H, Zhong J. Comparative efficacy of different combinations of acapella, active cycle of breathing technique, and external diaphragmatic pacing in perioperative patients with lung cancer: a randomised controlled trial. BMC Cancer. 2023 Mar 28;23(1):282. doi: 10.1186/s12885-023-10750-4.

    PubMed 36978035

Questions about this trial

What is this clinical trial studying?

A study testing ACBT training, acpella®PEP and EDP-type II external diaphragm pacemaker in people with Rehabilitation, run by Sun Yat-sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jiudi Zhong, Bachelor (+86 87343317, zhongjd@sysucc.org.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The change from baseline Forced Expiratory Volume In One Second at one month after surgery (time frame: baseline (before the surgery), and one month after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04914624, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in